About this trial
The objective of this observational study is to understand the long-term effects of traditional Chinese medicine (TCM) intervention on patients with cerebral infarction onset within \<48 hours and comorbid diabetes. The primary question it aims to address is:
Can long-term TCM intervention for the treatment of ischemic cerebrovascular disease comorbid with diabetes improve patients' neurological deficits and self-care ability? Participants receiving TCM intervention (universal treatment combined with syndrome-specific treatment) as part of routine cerebrovascular disease management will undergo follow-up assessments at 30 days, 90 days, 6 months, and 12 months within 1 year to evaluate neurological status (e.g., mRS score, NIHSS score) and quality of life indicators.
Eligibility criteria
Qualifiers
Age ≥ 18 years old, regardless of gender.
Fasting blood glucose ≥ 7.0 mmol/L.
2-hour postprandial blood glucose ≥ 11.1 mmol/L.
Glycated hemoglobin ≥ 6.5%.
Disqualifiers
None
Trial design
Treatments tested in this trial
- (Intensive treatment) Chuanzhi Tongluo Capsules
- Standard Treatment (Guideline-Based)
- (Sequential treatment) Chuanzhi Tongluo Capsules
- TCM Syndrome Differentiation Decoction